Fig. 2From: Effects of a pharmaceutical care intervention on clinical outcomes and patient adherence in coronary heart disease: the MIMeRiC randomized controlled trialThe proportion of patients who refilled their prescription for cholesterol-lowering (CL) drugs, and the proportion of patients who both refilled their prescription and reported adherence to their drug regimenBack to article page